Syndax Pharmaceuticals

Filed a patent for "methods of treating chronic graft-versus-host disease-related bronchiolitis obliterans syndrome using an anti-colony stimulating factor 1 receptor antibody" on Wed, May 17, 2023

Filed a patent for "selection of patients for combination therapy" on Thu, August 29, 2024

Filed a patent for "combinations of menin inhibitors and cyp3a4 inhibitors and methods of use thereof" on Thu, June 1, 2023

Filed a patent for "inhibitors of the menin-mll interaction" on Wed, November 8, 2023

Filed a patent for "selection of patients for combination therapy" on Thu, March 2, 2023

Filed a patent for "combination of hdac inhibitor and anti-pd-1 antibody for treatment of cancer" on Thu, January 26, 2023

Filed a patent for "menin-mll inhibitors for the treatment of cancer" on Mon, May 9, 2022